Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
| Sales | 6 | 185 | 89 | 22 | 10 |
| Cost of Goods | 6 | 48 | 9 | 13 | 4 |
| Gross Profit | 0 | 68 | 80 | 9 | 6 |
| Operating Expenses | 428 | 2,805 | 1,984 | 1,079 | 679 |
| Operating Income | -422 | -2,620 | -1,895 | -1,057 | -669 |
| Interest Expense | 0 | 30 | 0 | 9 | 15 |
| Other Income | 94 | 313 | 239 | -18 | 136 |
| Pre-tax Income | -328 | -2,337 | -1,656 | -1,084 | -548 |
| Income Tax | 0 | 0 | 0 | 0 | 7 |
| Net Income Continuous | -328 | -2,337 | -1,656 | -1,084 | -554 |
| Net Income | $-328 | $-2,337 | $-1,656 | $-1,084 | $-554 |
| EPS Basic Total Ops | -0.03 | -0.27 | -0.20 | -0.13 | -0.07 |
| EPS Basic Continuous Ops | -0.03 | -0.22 | -0.19 | -0.13 | -0.07 |
| EPS Diluted Total Ops | -0.03 | -0.22 | -0.19 | -0.13 | -0.07 |
| EPS Diluted Continuous Ops | -0.03 | -0.22 | -0.19 | -0.13 | -0.07 |
| EBITDA(a) | $-422 | $-2,620 | $-1,895 | $-1,057 | $-669 |